InvestorsObserver is giving Flexion Therapeutics Inc (FLXN) an Analyst Rating Rank of 64, meaning FLXN is ranked higher by analysts than 64% of stocks. The average price target for FLXN is $19.333 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating FLXN a Strong Buy today. Find out what this means to you and get the rest of the rankings on FLXN!